In vivo study of anticancer activity of ginsenoside Rh2-containing arginine-reduced graphene in a mouse model of breast cancer
Objective(s): This study aims to evaluate the in vivo anticancer activity of arginine-reduced graphene (Gr-Arg) and ginsenoside Rh2-containing arginine-reduced graphene (Gr-Arg-Rh2). Materials and Methods: Thirty-two mice with breast cancer were divided into four groups and treated every three days...
Main Authors: | Shervindokht Farhangfar, Farzaneh Fesahat, Hadi Zare-Zardini, Mahdi Dehghan-Manshadi, Fateme Zare, Seyed Mohsen Mirsmaeili, Maryam Vajihinejad, Hossein Soltaninejad |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2022-12-01
|
Series: | Iranian Journal of Basic Medical Sciences |
Subjects: | |
Online Access: | https://ijbms.mums.ac.ir/article_21217_e65e14e4e4673f867b0a416cfe76a349.pdf |
Similar Items
-
Anticancer activity of ginsenosides Rh2 on various cancer cells
by: Seun Eui Kim, et al.
Published: (2023-09-01) -
Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study
by: Zare-Zardini H, et al.
Published: (2020-08-01) -
Glycosyltransformation of ginsenoside Rh2 into two novel ginsenosides using recombinant glycosyltransferase from Lactobacillus rhamnosus and its in vitro applications
by: Dan-Dan Wang, et al.
Published: (2021-01-01) -
Biotransformation of Ginsenoside Rf to Rh1 by Recombinant β-Glucosidase
by: Yi-Nan Zheng, et al.
Published: (2009-06-01) -
Protective effect of ginsenoside Rh3 against anticancer drug-induced apoptosis in LLC-PK1 kidney cells
by: Hye Lim Lee, et al.
Published: (2017-04-01)